VIVUS, Inc. NASDAQ: $VVUS [Trend Analysis] along with Auxilium Pharmaceuticals, Inc. (AUXL) recently declared that the FDA has permitted their erectile dysfunction (ED) drug, Stendra’s supplemental new drug application (sNDA) to include 15 minutes onset of action. VIVUS has teamed up for the drug with privately -held Italian pharmaceutical firm, Menarini (over 40 European countries, Australia and New Zealand), Sanofi (Africa, the Middle East, Turkey, and the Commonwealth of Independent States including Russia) and Auxilium Shares of VIVUS, Inc. (NASDAQ:VVUS)
News 
Market Data 
Discover 
